Beyond pancreatic beta-cell and metabolic research, sema has been investigated in models of cardiovascular disease, kidney function, liver steatosis, and neurodegeneration
GLP-1 medications are designed to lower blood sugar in a glucose-dependent way, meaning they usually only work when your sugar is high
Protein supports muscle repair and maintenance, especially during periods of reduced calorie intake
Please note that its crucial to consult with a healthcare professional before starting any peptide regimen, as dosing needs to be tailored to individual conditions
From official prescribing information and pharmacology studies: Mounjaro (tirzepatide) has an elimination half-life of about 5 days
In published research, GLP-1 receptor activation has been associated with satiety signaling and glucose regulation, while GIP receptor activation has been investigated for its role in insulin physiology and metabolic homeostasis [1]